These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8905740)

  • 41. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
    Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
    Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
    Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats.
    Datla KP; Zbarsky V; Dexter DT
    J Neural Transm (Vienna); 2006 May; 113(5):583-91. PubMed ID: 16082506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preservation of dopamine release in the denervated striatum.
    Altar CA; Marien MR
    Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GBR-12909-induced self-injurious behavior: role of dopamine.
    Sivam SP
    Brain Res; 1995 Sep; 690(2):259-63. PubMed ID: 8535847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication.
    Opacka-Juffry J; Ashworth S; Sullivan AM; Banati RB; Blunt SB
    J Neural Transm (Vienna); 1996; 103(12):1429-34. PubMed ID: 9029409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
    Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.
    Agim ZS; Cannon JR
    Toxicol Lett; 2018 May; 287():31-41. PubMed ID: 29378243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus.
    Sloot WN; van der Sluijs-Gelling AJ; Gramsbergen JB
    J Neurochem; 1994 Jan; 62(1):205-16. PubMed ID: 7505311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism.
    Zigmond MJ; Berger TW; Grace AA; Stricker EM
    Mol Chem Neuropathol; 1989 Jun; 10(3):185-200. PubMed ID: 2504173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
    Van Kampen JM; McGeer EG; Stoessl AJ
    Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B; Dluzen DE
    Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.